Pharmaceutical company Eli Lilly is making a plea to some of its customers: stop hoarding our weight loss drugs. In a new Oscar-themed commercial set to run on TV this weekend, the drugmaker is not-so-subtly telling people to stay away from its new blockbuster medications if they’re only looking to lose a few pounds.…
Another week, another study finding that Ozempic/Wegovy and similar drugs may do a lot more than just help people lose weight. New research has found that patients who start taking GLP-1 drugs are less likely to be diagnosed with depression and anxiety afterward, compared to similar patients not on the drug. The…
Your snack habit may be even more calorie-dense than you think, recent research suggests. A study estimated that snacking contributes to around 20% of an average American’s daily caloric intake, and these snacks often add little nutritional value. The scientists found, though, that people with type 2 diabetes seem to…
New research shows that tirzepatide, the latest FDA-approved obesity drug, really can help people lose substantial amounts of weight—but only if they continue taking it. The study found that people who stopped taking tirzepatide after 36 weeks regained much of their lost weight within a year, while those who continued…
A study out this week suggests that semaglutide—the active ingredient in popular obesity drug Wegovy—might be able to help people struggling with alcohol use disorder, too. In a small sample of cases, researchers found evidence that people who took semaglutide for weight loss also experienced a significant reduction…
There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly injectable drug will be sold under the brand name Zepbound.
Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterfeit products. Residents have reportedly been hospitalized with…
MIT scientists might be one step closer to making insulin injections a thing of the past. In a new study this week, they’ve shown that it’s possible to implant a medical device inside mice that produces its own supply of insulin for up to a month. More research will be needed before this technology would be widely…
A lab-made antibody could one day make organ transplants less of an ordeal, recent research suggests. In experiments with nonhuman primates, the antibody appeared to be safe and effective at preventing the rejection of transplanted kidneys and pancreatic cells. Scientists hope that this treatment could reduce or even…
Being a night owl might not be great for your blood sugar control, new research this week suggests. The study found that middle-aged women who prefer to stay up late were more likely to develop type 2 diabetes. This associated link was found even after the researchers accounted for other unhealthy behaviors more…
